Correlation Between Oracle and Tevogen Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oracle and Tevogen Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Tevogen Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oracle and Tevogen Bio Holdings, you can compare the effects of market volatilities on Oracle and Tevogen Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Tevogen Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Tevogen Bio.

Diversification Opportunities for Oracle and Tevogen Bio

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Oracle and Tevogen is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Tevogen Bio Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tevogen Bio Holdings and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Tevogen Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tevogen Bio Holdings has no effect on the direction of Oracle i.e., Oracle and Tevogen Bio go up and down completely randomly.

Pair Corralation between Oracle and Tevogen Bio

Given the investment horizon of 90 days Oracle is expected to generate 2.4 times less return on investment than Tevogen Bio. But when comparing it to its historical volatility, Oracle is 9.65 times less risky than Tevogen Bio. It trades about 0.1 of its potential returns per unit of risk. Tevogen Bio Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  478.00  in Tevogen Bio Holdings on September 4, 2024 and sell it today you would lose (360.00) from holding Tevogen Bio Holdings or give up 75.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy41.41%
ValuesDaily Returns

Oracle  vs.  Tevogen Bio Holdings

 Performance 
       Timeline  
Oracle 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Oracle are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal fundamental indicators, Oracle disclosed solid returns over the last few months and may actually be approaching a breakup point.
Tevogen Bio Holdings 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tevogen Bio Holdings are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Tevogen Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Oracle and Tevogen Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oracle and Tevogen Bio

The main advantage of trading using opposite Oracle and Tevogen Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Tevogen Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will offset losses from the drop in Tevogen Bio's long position.
The idea behind Oracle and Tevogen Bio Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume